Gentian Diagnostics ASA (FRA:6FK)
4.780
+0.080 (1.70%)
At close: Jan 5, 2026
48.45% (1Y)
| Market Cap | 76.10M |
| Revenue (ttm) | 14.72M |
| Net Income (ttm) | 3.65M |
| Shares Out | n/a |
| EPS (ttm) | 0.23 |
| PE Ratio | 20.85 |
| Forward PE | 55.91 |
| Dividend | 0.03 (0.72%) |
| Ex-Dividend Date | May 7, 2025 |
| Volume | n/a |
| Average Volume | n/a |
| Open | 4.780 |
| Previous Close | 4.700 |
| Day's Range | 4.780 - 4.780 |
| 52-Week Range | 3.220 - 5.420 |
| Beta | n/a |
| RSI | 59.73 |
| Earnings Date | Feb 11, 2026 |